COL114883-TaqPath RNase P 2.0 Image-1400x400

This product is only available to clinical laboratories conducting testing for COVID-19. Regulations prohibit us from providing this product to individual customers.

Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU). Product availability by country varies.

Prepare for emerging mutations with an advanced COVID-19 test

Scientists predict that SARS-CoV-2 variants will continue to emerge, as persistent uncontrolled transmission of SARS-CoV-2 in many parts of the world and selective pressures, such as vaccines, are creating ideal conditions for additional, significant virus evolution.

Prepare for the unknown and unexpected with the TaqPath RNase P Combo Kit 2.0—designed with an innovative, multi-target assay design to compensate for current and future emerging SARS-CoV-2 mutations.

Features of this kit include:

  • RNase P human sample confirmation
  • Innovative, multi-target design to compensate for emerging mutations
  • Sensitive detection for symptomatic cases

Fill out the form and read the poster and application note to learn more.

RNasePComboPoster_EMEA
TaqPath-Fast-PCR-App-Note
*
*
*
*
*
*
*
 Yes
 No
 
 

Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU). Product availability by country varies.